Biotech startup Accure gets FDA clearance for acne-treatment system

BOULDER — Accure Acne Inc., a biotechnology startup that’s developing a laser system to treat acne, has received the U.S. Food and Drug Administration’s blessing to sell its product for treatment of mild to severe inflammatory acne vulgaris.

“The Accure Laser System builds upon the unique selectivity of the 1726nm laser wavelength, adding proprietary technology to precisely control thermal gradient depth,” the company said in a news release. “This technology breakthrough is accomplished through a unique pulsing algorithm, integrated temperature monitoring, and precise automated control of the laser.”

Accure’s clinical development program was led by Emil Tanghetti at the Center for Dermatology…